Unique Ingredient Identifier 1I96OHX6EK is listed as a ingredient substance
| RN | 128446-35-5 |
| EC | 603-269-8 |
| RXCUI | 1363608 |
| MF | C60H106O40 |
| SMILES | CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1C[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7OCC(C)O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](OCC(C)O)[C@H]4O)[C@H](OC |
UNII 1I96OHX6EK HYDROXYPROPYL BETADEX is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| INTRAMUSCULAR | INJECTION | 33.33 %W/V |
| INTRAVENOUS | INJECTION | 94.1 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 20 % |
| IV(INFUSION) | INJECTION | 33.33 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 15 % |
| ORAL | SOLUTION | 400 MG/1ML |
| ORAL | TABLET, ORALLY DISINTEGRATING | 15 MG |